Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017

In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Sheena G, Chilver, Monique B, Carville, Kylie S, Deng, Yi-Mo, Grant, Kristina A, Higgins, Geoff, Komadina, Naomi, Leung, Vivian KY, Minney-Smith, Cara A, Teng, Don, Tran, Thomas, Stocks, Nigel, Fielding, James E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2017
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718387/
https://www.ncbi.nlm.nih.gov/pubmed/29090681
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707
Descripción
Sumario:In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.

Ejemplares similares